Cargando…

Radiation Induced Abscopal Effect in a Patient With Malignant Pleural Mesothelioma on Pembrolizumab

Abscopal effect is a rare phenomenon in which treatment benefit from radiotherapy (RT) is seen outside the target field due to activation of the immune system inducing an anti-tumor effect. This phenomenon has been reported in cancer patients receiving immune checkpoint inhibitors (ICI). Here we rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rittberg, Rebekah, Chan, Elisa, Yip, Stephen, Alex, Deepu, Ho, Cheryl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Radiation Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920754/ https://www.ncbi.nlm.nih.gov/pubmed/35308690 http://dx.doi.org/10.7759/cureus.22159

Ejemplares similares

First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural Mesothelioma
por: Barsky, Andrew R, et al.
Publicado: (2019)

Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab
por: Mampuya, Wambaka Ange, et al.
Publicado: (2021)

Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab
por: Tsui, James M, et al.
Publicado: (2018)

Compensator‐based intensity‐modulated radiation therapy for malignant pleural mesothelioma post extrapleural pneumonectomy
por: Javedan, Khosrow, et al.
Publicado: (2008)

Abscopal Effect, From Myth to Reality: From Radiation Oncologists' Perspective
por: Yilmaz, Melek Tugce, et al.
Publicado: (2019)

Radiation Therapy and its Effects Beyond the Primary Target: An Abscopal Effect
por: Wani, Shaqul Qamar, et al.
Publicado: (2019)

Radiation Therapy as a Modality to Create Abscopal Effects: Current and Future Practices
por: Adjepong, Dennis, et al.
Publicado: (2020)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

A pilot study of volumetric‐modulated arc therapy for malignant pleural mesothelioma
por: Runxiao, Li, et al.
Publicado: (2016)

Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
por: Hearon, Bernard F., et al.
Publicado: (2020)

Abscopal Effects: Case Report and Emerging Opportunities
por: Lock, Michael, et al.
Publicado: (2015)

A Review of the Abscopal Effect in the Era of Immunotherapy
por: Nabrinsky, Edward, et al.
Publicado: (2022)

Extracranial Abscopal Responses after Radiation Therapy for Intracranial Metastases: A Review of the Clinical Literature and Commentary on Mechanism
por: Gui, Chengcheng, et al.
Publicado: (2019)

Abscopal Effect of Radiotherapy in Imatinib-resistant Dermatofibrosarcoma Protuberans
por: Agyeman, Mervin B, et al.
Publicado: (2019)

Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
por: Wadowski, Benjamin, et al.
Publicado: (2021)

Intensity‐modulated radiotherapy and volumetric‐modulated arc therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy
por: Krayenbuehl, Jerome, et al.
Publicado: (2013)

Current State of Pleural-Directed Adjuncts Against Malignant Pleural Mesothelioma
por: Choi, Agnes Y., et al.
Publicado: (2022)

Radio-Immunotherapy: A Case Report of ‘Abscopal Hyper-Progression’?
por: Koukourakis, Ioannis M, et al.
Publicado: (2020)

New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma
por: Rossini, Marika, et al.
Publicado: (2018)

Abscopal Effect of Radiotherapy in the Immunotherapy Era: Systematic Review of Reported Cases
por: Dagoglu, Nergiz, et al.
Publicado: (2019)

Boosting Abscopal Response to Radiotherapy with Sargramostim: A Review of Data and Ongoing Studies
por: Leary, Robyn, et al.
Publicado: (2019)

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
por: Cantini, Luca, et al.
Publicado: (2020)

Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma
por: Bickel, Angelika, et al.
Publicado: (2016)

Pembrolizumab-Induced Immune-Mediated Glossitis
por: Alias, Alwin, et al.
Publicado: (2022)

Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
por: Cavallari, Ilaria, et al.
Publicado: (2019)

Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma
por: Belderbos, Robert A., et al.
Publicado: (2020)

Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
por: Nicolini, Fabio, et al.
Publicado: (2020)

Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016
por: Thomas, Akesh, et al.
Publicado: (2021)

Editorial: Advances in malignant pleural mesothelioma: Diagnosis, treatment, and molecular mechanisms
por: Mastromarino, Maria Giovanna, et al.
Publicado: (2023)

Abscopal Effect after Radiosurgery for Solitary Brain Metastasis from Non-small Cell Lung Cancer
por: Hamilton, Andrew J, et al.
Publicado: (2018)

The Abscopal Effect Exists in Non-small Cell Lung Cancer: A Case Report and Review of the Literature
por: Bitran, Jacob
Publicado: (2019)

Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets
por: Cavallari, Ilaria, et al.
Publicado: (2023)

Systemic benefit of radiation therapy via abscopal effect
por: Craig, Daniel J., et al.
Publicado: (2022)

MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review
por: Lo Russo, Giuseppe, et al.
Publicado: (2018)

Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight
por: Xu, Duo, et al.
Publicado: (2020)

Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma
por: Xu, Xiaoling, et al.
Publicado: (2020)

Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future
por: Reid, Glen, et al.
Publicado: (2020)

Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation
por: Ferrari, Luca, et al.
Publicado: (2020)

Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma
por: Tostes, Francinne T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3f4j7eol4qqoqqgtu9epdgeqfo